APA (7th ed.) Citation

Marina Piljić Burazer, Suzana Mladinov, Antonela Matana, Sendi Kuret, Joško Bezić, & Merica Glavina Durdov. (2019). Low ERCC1 expression is a good predictive marker in lung adenocarcinoma patients receiving chemotherapy based on platinum in all TNM stages - a single-center study. BMC.

Chicago Style (17th ed.) Citation

Marina Piljić Burazer, Suzana Mladinov, Antonela Matana, Sendi Kuret, Joško Bezić, and Merica Glavina Durdov. Low ERCC1 Expression Is a Good Predictive Marker in Lung Adenocarcinoma Patients Receiving Chemotherapy Based on Platinum in All TNM Stages - a Single-center Study. BMC, 2019.

MLA (9th ed.) Citation

Marina Piljić Burazer, et al. Low ERCC1 Expression Is a Good Predictive Marker in Lung Adenocarcinoma Patients Receiving Chemotherapy Based on Platinum in All TNM Stages - a Single-center Study. BMC, 2019.